Major institutional investor signals confidence in RF microneedling and radiofrequency device maker.
Wellington Management Group, a Boston-based institutional investor with $1.1 trillion in assets under management, has purchased $1.25 million of InMode Ltd. stock, signaling institutional confidence in the RF device manufacturer. The move is modest in absolute terms but meaningful as a vote of confidence from a tier-one asset manager.
InMode's core franchise—Morpheus8 RF microneedling and Forma radiofrequency skin tightening—has proven durable through multiple device cycles. The company's recent launch of Morpheus8 Cool, which adds cryogenic cooling to reduce post-treatment erythema and discomfort, addresses a real clinical friction point. Cooled RF microneedling is a feature set that justifies premium pricing and improves patient compliance.
Wellington Management's $1.25M stake signals institutional confidence in RF device makers.
For practice owners, institutional buying is a leading indicator of sector health. Wellington's entry suggests that large-cap asset managers see RF device makers as stable, profitable, and defensible against disruption. This typically precedes analyst upgrades and increased institutional ownership, which can support stock appreciation for publicly traded device companies.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
